Categories
rss rss-es rss-pt

Smiths Medical Recalls NORMOFLO Irrigation Fluid Warmers and Warming Sets Due to the Possibility of Harmful Levels of Aluminum Leaching into the Fluid Path of the Warmers

Murilo Freitas - 04:00, 14 de septiembre de 202118
Smiths Medical ASD Inc is recalling the NORMOFLO Irrigation Fluid Warmer and Warmers Sets because of the potential for aluminum ions leaching into warmed fluids.

http://www.fda.gov/medical-devices/medical-device-recalls/smiths-medical-recalls-normoflo-irrigation-fluid-warmers-and-warming-sets-due-possibility-harmful

 
Categories
rss rss-es rss-pt

Urgent Voluntary Recall: Level 1 Fast Flow Fluid Warming System, NORMOFLO Fluid Warmer and Level 1 Normothermic I.V. Fluid Administration Set

Murilo Freitas - 04:00, 14 de septiembre de 202119
Level 1® Fast Flow Fluid Warming System, NORMOFLO® Fluid Warmer and Level 1® Normothermic I.V. Fluid Administration Set manufactured by Smiths Medical ASD Inc.

http://www.fda.gov/vaccines-blood-biologics/recalls-biologics/urgent-voluntary-recall-level-1-fast-flow-fluid-warming-system-normoflo-fluid-warmer-and-level-1

 
Categories
rss rss-es rss-pt

Fallecimientos relacionados al COVID-19 aumentaron en casi 40%: en promedio se registran 27 decesos diarios

Murilo Freitas - 21:14, 13 de septiembre de 202115

Fallecimientos relacionados al COVID-19 aumentaron en casi 40%: en promedio se registran 27 decesos diarios

Primera semana de septiembre se convierte en la segunda con mayor cantidad de casos COVID-19Martes 14 de setiembre, 2021. La semana del 5 al 11 setiembre contabilizó 187 decesos relacionados al COVID-19...

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2168-fallecimientos-relacionados-al-covid-19-aumentaron-en-casi-40-en-promedio-se-registran-27-decesos-diarios

 
Categories
rss rss-es rss-pt

Jacobus Pharmaceutical Company Inc. Issues Voluntary Worldwide Recall of Ruzurgi® (amifampridine) 10 mg Tablets Due to Yeast, Mold, and Bacterial Contamination

Murilo Freitas - 04:00, 12 de septiembre de 202115
Plainsboro, New Jersey, Jacobus Pharmaceutical Company Inc. is voluntarily recalling 3 lots of Ruzurgi® (amifampridine) 10 mg tablets to the consumer level. The products have been found to be contaminated with yeast, mold, and aerobic bacteria based on laboratory test results. Oral products heavily

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/jacobus-pharmaceutical-company-inc-issues-voluntary-worldwide-recall-ruzurgir-amifampridine-10-mg

 
PRAIS 2.0